NDC 80425-0171-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0171
- Requested NDC
- 80425-0171-01
- Package NDCs from labels
- 80425-0171-3, 80425-0171-2, 80425-0171-1, 80425-0171-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0171-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 8 | |
| 80425-0171-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 8 | |
| 80425-0171-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0171 | METHOCARBAMOL TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_c9600cc9-7e27-6e19-e053-2995a90ab024.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0171-1 | EA - Each | 80425-0171 | cdc53f27-e0d3-4ffb-8af5-d419758d22bc | 1 | 2023-06-06 |
| 80425-0171-2 | EA - Each | 80425-0171 | 04ca45d9-2d21-4e99-8b9a-247d01ab4b7b | 1 | 2023-06-06 |
| 80425-0171-3 | EA - Each | 80425-0171 | afb9cb2e-d86c-48b1-bb44-f5928747d6fe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 39b4362e-a26e-49cb-9d06-898bc9b0e005 | 2021-04-01 | Warnings, Adverse reactions | ANDA208507 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Sagent Pharmaceuticals | bc925726-4949-4647-bce8-e1180d36abe4 | 2021-03-12 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 75b964b7-3e76-4460-9777-7656b5daa32e | 2020-12-01 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarb 500-EZS | METHOCARBAMOL | PureTek Corporation | 383ce408-1085-43e7-944e-957ff2a9d553 | 2020-11-10 | Warnings, Adverse reactions | 197943 |
| methocarbamol | METHOCARBAMOL | Baxter Healthcare Corporation | a7f70b19-75ba-4e3d-b4fe-277fe7305bf0 | 2020-09-28 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | 0003eccd-6147-4a7c-ae83-b2a94933e07d | 2020-08-01 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Gland Pharma Limited | 44c7fe99-8999-4747-9376-f13d3f9e5688 | 2020-07-18 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Meitheal Pharmaceuticals Inc. | b60000fc-e99b-4994-9d36-3907e0da9e06 | 2019-12-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Dr.Reddys Laboratories Inc., | c88898af-5cd8-7bed-a03e-2ab4488e2040 | 2018-11-30 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | d825e4d6-8b00-473a-a6e6-90f5c3ad5bec | 2018-10-24 | Warnings, Adverse reactions | ANDA208507 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Aphena Pharma Solutions - Tennessee, LLC | 3757cd8e-6054-4b75-bb04-d11f34c65cbe | 2018-09-12 | Warnings, Adverse reactions | 197944 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.